In This Article:
Potential CardioComm Solutions, Inc. (CVE:EKG) shareholders may wish to note that the Independent Director, Daniel Grima, recently bought CA$295k worth of stock, paying CA$0.01 for each share. We reckon that's a good sign, especially since the purchase boosted their holding by 427%.
View our latest analysis for CardioComm Solutions
CardioComm Solutions Insider Transactions Over The Last Year
In fact, the recent purchase by Daniel Grima was the biggest purchase of CardioComm Solutions shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of CA$0.01. Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.
While CardioComm Solutions insiders bought shares during the last year, they didn't sell. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
CardioComm Solutions is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Insider Ownership Of CardioComm Solutions
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Our data indicates that CardioComm Solutions insiders own about CA$258k worth of shares (which is 13% of the company). But they may have an indirect interest through a corporate structure that we haven't picked up on. We do generally prefer see higher levels of insider ownership.
What Might The Insider Transactions At CardioComm Solutions Tell Us?
The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that CardioComm Solutions insiders are expecting a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To help with this, we've discovered 5 warning signs (4 are significant!) that you ought to be aware of before buying any shares in CardioComm Solutions.